{"version":"1.0","type":"link","title":"Co-treatment of Colchicine and Rosiglitazone synergistically inhibits cytokine-driven inflammation and modulates the related hsa-miRNA26a-5p, hsa-miRNA21-5p, and STAT3 expression in non-small cell lung cancer.","author_name":"Younes N 외","author_url":"https://prs-insight.online/author/Younes%20N","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/93921","thumbnail_width":1200,"thumbnail_height":630}